Answers are grounded in this paper and cite their sources.
Cerebral small vessel disease (CSVD) markers are increasingly reported in schizophrenia-spectrum disorders (SSD), but their age-related distribution and phenotypic heterogeneity within young-to-middle-aged clinical populations remain unclear. This study aimed to characterise age gradients of CSVD markers, latent imaging phenotypes, and their clinical and biomarker correlates in a real-world inpatient SSD cohort. Consecutive SSD inpatients aged 18–55 years who underwent brain magnetic resonance imaging at a tertiary mental hospital during 2023–2024 were included ( N = 1,043). CSVD markers were visually rated using Standards for Reporting Vascular Changes on Neuroimaging (STRIVE)-based criteria. A 3-marker CSVD score summarised confluent white matter hyperintensities (WMH), moderate-to-severe basal ganglia perivascular spaces, and lacunes. Latent class analysis was used to derive imaging phenotypes, and classification-error-corrected three-step regression examined demographic, clinical, vascular-metabolic, and circulating biomarker correlates. Composite CSVD burden was present in 11.70% of participants, increasing from 3.11% at ages 18–29 years to 37.18% at ages 50–55 years. The selected three-class LCA solution yielded three exploratory imaging profiles: Low-lesion (52.92%), WMH-predominant (29.43%), and Mixed-marker high-burden (17.64%). The WMH-predominant phenotype peaked in the midlife age bands, whereas the Mixed-marker high-burden phenotype increased progressively with age and was most frequent in the oldest group. Age was the strongest correlate of membership in both non-Low-lesion phenotypes. Female sex was associated with the WMH-predominant phenotype, whereas no circulating biomarker associations remained significant after FDR correction. CSVD markers in young-to-middle-aged SSD inpatients showed pronounced age gradients and were organised into three exploratory latent imaging profiles. This phenotype-based framework may help characterise heterogeneous cerebrovascular involvement in SSD and inform future longitudinal, comparative, and mechanistic studies. Not applicable.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: